EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Navigating the AI Transformation in Healthcare

    Real Chemistrys expansion into Zurich is part of our broader objective to help clients by scaling internationally while maintaining a local mindset We are bringing our connected capabilities to one of Europes most influential hotspots sitting at the intersection of science innovation and investment This convergence is ideal for collaboration

KNOWLEDGE BANK

  • Articles

    Trapicolast Emerges as a First-In-Class Response to Drug Resistance: The Weakest

    Malaria remains one of the worlds most persistent infectious diseases Each year it infects hundreds of millions and causes more than half a million deaths with subSaharan Africa bearing the overwhelming burden Children under five account for most fatalities highlighting malarias deep inequity

    The Synergy of Bioinformatics and Computational Biology in Genome Analysis

    In the dynamic field of biological sciences the fusion of bioinformatics and computational biology has catalyzed a paradigm shift in genome analysis This synergistic collaboration harnesses cuttingedge computational tools statistical models

    Fundamentals of Pharmaceutical Formulation Development

    The process of changing an active drug substance into a safe and effective drug is much more complicated than it seems at first sight The core of this undertaking is pharmaceutical formulation development a science and strategic field that unites the pursuit of striking a scientific breakthrough and patient care Even the most promising drug molecule would not confer therapeutic benefits without be...

    Regulatory Challenges in Clinical Testing for New Pharmaceuticals

    The clinical testing is a stage where the new pharmaceutical products are a trial on human beings or patients The aims of clinical trials are to assess the effectivenesssafetytolerability or intolerance of new drug in man Generally clinical trials are conducted in phases each phase has different questions regarding the drug

    Role of QSAR in filling in the gaps of CoVID-19 Therapeutics

    Since initial reports from Wuhan China in December and the subsequent declaration of a global pandemic by the WHO in March CoVID has precipitated the greatest health crisis in modern history While exposing fundamental weaknesses in healthcare systems across the globe this tragedy has also been an opportunity for scientists and researchers in different fields to collaborate and produce solutions...

    From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma

    Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes

TOP ARTICLES

  • 2

    Fundamentals of Pharmaceutical Formulation Development

    Kate Williamson

    Drug innovation is a principal responsibility of pharmaceutical formulation development that provides the drug with stability, bioavailability, and adherence in the patients. Researchers can make mole...

  • 4

    Role of QSAR in filling in the gaps of CoVID-19 Therapeutics

    Smriti Sharma Bhatia

    Yousuf Khan

    Kunika Saini

    QSAR modelling has been used extensively as an efficient method in the process of drug development against CoVID-19. The rapid spread and devastating impact of this viral disease across the globe requ...

press releases Read more...

Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)

H Lundbeck AS Lundbeck today announced that the last patient has been randomized in DEEp OCEAN NCT a global Phase III clinical trial evaluating the efficacy safety and tolerability of bexicaserin

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Amneal Pharmaceuticals Inc today announced that it has received US Food and Drug Administration FDA approval for additional strengths and vial presentations of iohexol injection mg iodinemL in mL mL

Aqemia and Sanofi Expand Their Research Collaboration

Aqemia the drug invention company combining generative AI and quantuminspired physics to invent small molecule drugs today announced the expansion of its multiyear research collaboration with the global pharmaceutical company

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

Forecasting insights and analytics is a strategic decisionmaking function within global product strategy and commercial departments in pharmaceutical companies Unlike operational or salesfocused functions

20 - 22

Jul 2026

6th mRNA-Based Therapeutics Summit

The Westin Boston Seaport Dist...

20 - 22

Jul 2026

24 - 25

Jul 2026

26 - 30

Jul 2026

ADLM 2026

Anaheim, CA USA

27 - 28

Jul 2026

27 - 28

Jul 2026

27 - 28

Jul 2026

28 - 30

Jul 2026

5th In Vivo Cell & Gene Summit 2026

500 Commonwealth Avenue, Bosto...

LATEST NEWS Read more...

Dyne Therapeutics’ BLA for Z-Rostudirsen Accepted by FDA for Review in Exon 51 Duchenne Muscular Dystrophy

Dyne Therapeutics has announced that the US Food and Drug Administration FDA has accepted its Biologics License Application BLA for zeleciment rostudirsen zrostudirsen also known as DYNE

European Commission approves JASCAYD® for IPF and PPF treatment in the EU

The European Commission EC has granted marketing authorisation for JASCAYD nerandomilast for the treatment of adults with idiopathic pulmonary fibrosis IPF and progressive pulmonary fibrosis PPF Boehringer Ingelheim announced

ThalassaX Therapeutics doses first patient in U.S. Phase I trial of CS231295

ThalassaX Therapeutics United States Ltd has announced that the first patient has been dosed in its US Phase I clinical trial of CS a brainpenetrant Aurora B kinase selective inhibitor developed

Boehringer Ingelheim Advances Obesity Pipeline with Phase II Trial of Triple Receptor Agonist

Boehringer Ingelheim has started a Phase II clinical trial of BI an investigational triple GLPGIPNPY receptor agonist for the treatment of people with obesity and overweight

Umoja Biopharma Receives FDA Clearance to Begin Clinical Trial of UB-VV400 In Vivo CAR T Cell Therapy

Umoja Biopharma has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for UBVV a CDdirected in vivo CAR T cell therapy for adults

Sinopia Biosciences Publishes Preclinical Study Supporting SB-0110 for Parkinson's Disease

Sinopia Biosciences has published preclinical research in Science Translational Medicine highlighting a new approach to treating Parkinsons disease The study supports the development of SB